Alan Gilbert Goodman

CeNeS Pharmaceuticals Plc engages in the discovery and development of drugs. The company was founded by Alan Gilbert Goodman in 1997 and is headquartered in Cambridge, the United Kingdom.

PA Consulting Group Ltd. engages in the provision of management, systems, technology consulting, and innovation services. The company was founded by Ernest Button on September 3, 2015 and is headquartered in London, the United Kingdom.

CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom.

Institute for Translational Vaccinology is a Dutch independent company that partners with clients in vaccine development, from discovery to pilot production to clinical studies. The non-profit company is based in Bilthoven, Netherlands. Intravacc designs and creates the best candidate organisms for vaccine strain, looking for the highest immunity, potency, and production yield. The company substantially reduces the risks and costs involved with developing vaccines by bridging the gap between concept and late-stage clinical studies. Intravacc's upstream processing expertise covers both bacterial and cell cultivation as well as virus propagation in reactors ranging from 1l up to 200l. The company's scientists design, develop, and improve vaccine formulations that are suitable for the intended administration route and stable upon storage.

Van Eeghen & Co. BV is an investment company based in Amsterdam, Netherlands. The Dutch company operates as an investment firm.

Julius Clinical Research BV is a scientifically focused CRO that provides end-to-end clinical trial services to pharmaceutical and biotechnology customers, governments, and academia. The private company is based in the Netherlands and was founded in 2008. Julius Clinical's renowned scientific leaders are at the forefront of their fields, which combine with operational excellence and a network of research sites to deliver tailor-made solutions for customers and their clinical trials. The Dutch company has approximately 200 employees and has supported over 130 clinical trials, enrolling more than 200,000 participants in around 40 countries. Julius Clinical has a focus on the therapeutic areas of neurology, renal, cardiometabolic, and infectious diseases. The company uses its unique triangle of science, networks, and operations to provide tailored CRO and SMO services. Martijn Wallert has been the CEO of the company since 2021.

Humedics GmbH operates as a research-based medtech company. It focuses on rapid and precise lover function measurement using LiMax, a breath analysis technology. The company was founded by Martin Stockman, Erwin de Bujizer, and Karsten Heyne in 2009 and is headquartered in Berlin, Germany.

Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

Booz Allen Hamilton, Inc. engages in the provision of management and technology consulting services. Its services include consulting, analytics, digital solutions, engineering, cyber security, and product. The company was founded by Edwin G. Booz in 1914 and is headquartered in McLean, VA.

DSM BV engages in the provision of ingredients, expertise, and solutions for plant-based products. It operates through the following segments: Animal Nutrition and Health (ANH); Health, Nutrition, and Care (HNC); Food and Beverage (F and B); and Other. The ANH segment includes developing sustainable animal farming through essential products, performance solutions, and precision services serving the poultry, swine, ruminants, and aquaculture markets. The HNC segment provides health, nutrition, and care solutions for markets such as early life nutrition, dietary supplements, pharma, medical, and personal care. The F and B segment focuses on supporting healthy diets through nutritious, delicious, and sustainable solutions for several market segments including bakery, beverages and brewing, dairy, savory, plant-based alternative proteins, and pet food. The Other segment is involved in corporate activities. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

Strategy& engages in the provision of global management consulting services. It serves industries including aerospace and defense; health; oil and gas; technology; automotive; entertainment and media; power and utilities; telecommunications; and transportation. The company was founded in 1914 and is headquartered in New York, NY.

Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany.

Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.

Vitanova Biomedical, Inc. is a biotechnology company based in the United States that focuses on improving the lives of cancer patients and healthcare professionals. The private company is based in Kerrville, TX. The company aims to achieve this through the development and commercialization of their novel light-activated intracellular acidosis platform cancer therapy. Vitanova Biomedical is currently working on preclinical evidence to support progress towards regulatory clearance and market commercialization. The company was founded by Matt Gdovin and Greg Espenhover. Tom Roberts has been the CEO of the company since 2016.

Part of PAION AG, Paion UK Ltd. is a specialty pharmaceutical company that develops and commercializes innovative drugs for out-patient and hospital-based sedation and critical care services. Paion was founded in 1995 and is based in Cambridge, UK, with another site in Germany. Paion's vision is to become an acknowledged "PAIONeer" in sedation and critical care services. The British company's lead compound is remimazolam, an intravenous, ultra-short-acting and controllable benzodiazepine sedative/anesthetic drug candidate. The company is mainly focusing on completing the development program for procedural sedation and planning to continue the clinical development program for remimazolam in the indication general in the EU.

Part of PAION AG, PAION, Inc. is a pharmaceutical manufacturing company. The company is based in Mahwah, NJ.

Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany.

Part of PAION AG, Paion Holdings UK Ltd. functions as an investment holding company. The company is based in Edinburgh, UK. The British company was founded in 1996. Abdelghani Omari has been the CEO of the company since 2012.

Domus Diagnostics, Inc. is a company that aims to create affordable, user-friendly, accurate, and rapid tests for infectious diseases to address the needs raised by current and future public health crises. Domus Diagnostics seeks to change how infectious disease testing is done worldwide, with the goal of providing home testing for everyone, everywhere, to prevent future pandemics. The company was founded by John Reif, Harald F. Stock, and Xin Song, and is co-located in Durham and Park City, UT, with a product testing lab at the Research Triangle Park in North Carolina.

Consilient Health Ltd. engages in the manufacture and distribution of pharmaceuticals. The private company is based in Clonskea, Ireland, and has subsidiaries in the United Kingdom. Luke Crosbie has been the CEO of the Irish company since 2005.

Cognifisense, Inc. is a technology company based in Sunnyvale, CA. Cognifisense's core product is virtual reality neuropsychological therapy (VRNT), which is a patented virtual reality-based therapy designed to treat chronic pain. The therapy combines psychological therapies with the immersive power of VR to address the maladaptive neuroplastic changes in the brain that drive chronic pain. The company was founded by Tassilo Baeuerle and Harald F. Stock, with Tassilo Baeuerle serving as CEO since incorporation.

Quantum Diamond Technologies, Inc. develops and commercializes nanoscale devices. The company is headquartered in Somerville, MA.

Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

ArjoHuntleigh AB manufactures and sells medical devices and solutions for mobility, lifting, and wound care. Its products include floor and ceiling lifters; slings; medical and therapeutic beds; disinfectors; and VTE prevention devices. The company is headquartered in Malmö, Sweden.

DePuy Orthopaedics, Inc. engages in the design, manufacture, and distribution of orthopedic devices and supplies. Its products are used primarily by orthopedic medical specialists and spinal neurosurgeons in both surgical and non-surgical therapy. The company was founded on December 13, 2016 and is headquartered in Warsaw, IN.

Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland.

ERGO Group AG engages in the provision of insurance and financial services. Its business units include German, International, and Direct and digital business. The firm offers life insurance, health insurance, legal expenses insurance, property and casualty insurance, travel insurance, pension fund, and financial services. The company was founded on August 1, 1997 and is headquartered in Dusseldorf, Germany.

Virocell Biologics Ltd. is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials. The company is based in London, UK. The British company leverages its expertise in vector manufacture directly into the production of gene-modified cells, both adherent cells such as Mesenchymal Stromal/Stem cells and suspension cultures such as CAR T-cells. Virocell Biologics is committed to leveraging its deep experience to rapidly design and select a manufacturing strategy best suited to the client's objectives. The company was founded by Farzin Farzaneh, John W. Hadden. John W. Hadden has been the CEO since incorporation.

Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. develops ocular therapeutics and treatments for rare diseases. The private company is based in Beijing, CN. and has subsidiaries in the United States. The CEO of the Chinese company is Darren Mercer.

Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom.

The Magstim Co. Ltd. researches, develops, manufactures, and markets medical and research devices in the neurological and surgical fields. It offers instructions and commission, software upgrades, and repair services. The company was founded in 1990 and is headquartered in Whitland, the United Kingdom.